Weight management has become a global health challenge, with obesity rates climbing at alarming rates.
For many, the struggle to lose weight is not just about willpower – it’s influenced by genetics, lifestyle and underlying health conditions.
In South Africa, where Non-Communicable Diseases (NCDs) like diabetes, hypertension and obesity are on the rise, new medical interventions are offering hope.
One such breakthrough is GLP-1 receptor agonist (GLP-1 RA) medications, which are proving to be a game-changer in weight management.
The most commonly used GLP-1 medication is semaglutide, which is marketed as Ozempic, Wegovy.
These drugs, initially designed for managing type 2 diabetes, are now showing remarkable results in helping people lose significant amounts of weight.
Understanding GLP-1 medications
GLP-1 RAs mimic the action of glucagon-like peptide-1, a hormone released in…
